Literature DB >> 28089818

Notochordal cell-derived conditioned medium protects human nucleus pulposus cells from stress-induced apoptosis.

Arne Mehrkens1, Ajay Matta2, Muhammad Zia Karim2, Sarah Kim2, Michael G Fehlings3, Stefan Schaeren4, William Mark Erwin5.   

Abstract

BACKGROUND CONTEXT: Degenerative disc disease (DDD) remains without an effective therapy and presents a costly burden to society.
PURPOSE: Based upon prior reports concerning the effects of notochordal cell-conditioned medium (NCCM) on disc cells, we performed a proof of principle study to determine whether NCCM could reduce cytotoxic stress-induced apoptosis in human disc nucleus pulposus (NP) cells. STUDY DESIGN/
SETTING: This is an "in vitro" fundamental or basic science study.
METHODS: Nucleus pulpous cells derived from 15 patients undergoing spinal surgery were treated with interleukin (IL)-1β and Fas ligand or etoposide in the presence of NCCM. We determined pro- or antiapoptotic events using activated caspase assays and determined genomic regulation of apoptosis using polymerase chain reaction arrays validated using Western blotting methods. We interrogated cellular apoptotic regulation using JC-1 dye and flow cytometry and performed enzyme-linked immunosorbent assays to evaluate NP inflammatory cytokine secretion.
RESULTS: Notochordal cell-conditioned medium inhibits cytotoxic stress-induced caspase-9 and -3/7 activities and maintains the mitochondrial membrane potential in human NP cells, thereby suppressing the intrinsic apoptotic pathway. Gene expression analysis revealed the X-linked inhibitor of apoptosis protein as a key player responsible for evading etoposide-induced apoptosis in the presence of NCCM, and we verified these data using Western blotting. Enzyme-linked immunosorbent assay results revealed distinct differences in IL-6 and IL-8 secretions by NP cells in response to etoposide in the presence of NCCM.
CONCLUSIONS: Here we demonstrate for the first time that NCCM reduces cytotoxic stress-induced apoptosis in human NP cells. Soluble factors present in NCCM could be harnessed for the development of novel therapeutics for the treatment of DDD.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Cell proliferation; Cytokines; Degenerative disc disease; Human nucleus pulposus; Notochordal cell; X-linked inhibitor of apoptotic proteins

Mesh:

Substances:

Year:  2017        PMID: 28089818     DOI: 10.1016/j.spinee.2017.01.003

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  10 in total

1.  Differentiation of human induced pluripotent stem cells into nucleus pulposus-like cells.

Authors:  Ruhang Tang; Liufang Jing; Vincent P Willard; Chia-Lung Wu; Farshid Guilak; Jun Chen; Lori A Setton
Journal:  Stem Cell Res Ther       Date:  2018-03-09       Impact factor: 6.832

2.  NTG-101: A Novel Molecular Therapy that Halts the Progression of Degenerative Disc Disease.

Authors:  Ajay Matta; Muhammad Zia Karim; Hoda Gerami; Peter Jun; Martha Funabashi; Greg Kawchuk; Alyssa Goldstein; Warren Foltz; Marshall Sussman; Bjorn C Eek; W Mark Erwin
Journal:  Sci Rep       Date:  2018-11-14       Impact factor: 4.379

Review 3.  Critical aspects and challenges for intervertebral disc repair and regeneration-Harnessing advances in tissue engineering.

Authors:  Conor T Buckley; Judith A Hoyland; Kengo Fujii; Abhay Pandit; James C Iatridis; Sibylle Grad
Journal:  JOR Spine       Date:  2018-07-30

4.  NOTO Transcription Factor Directs Human Induced Pluripotent Stem Cell-Derived Mesendoderm Progenitors to a Notochordal Fate.

Authors:  Pauline Colombier; Boris Halgand; Claire Chédeville; Caroline Chariau; Valentin François-Campion; Stéphanie Kilens; Nicolas Vedrenne; Johann Clouet; Laurent David; Jérôme Guicheux; Anne Camus
Journal:  Cells       Date:  2020-02-24       Impact factor: 6.600

5.  Effect of lentivirus-mediated growth and differentiation factor-5 transfection on differentiation of rabbit nucleus pulposus mesenchymal stem cells.

Authors:  Kun Zhu; Rui Zhao; Yuchen Ye; Gang Xu; Changchun Zhang
Journal:  Eur J Med Res       Date:  2022-01-13       Impact factor: 2.175

Review 6.  Current Status of the Instructional Cues Provided by Notochordal Cells in Novel Disc Repair Strategies.

Authors:  Ajay Matta; William Mark Erwin
Journal:  Int J Mol Sci       Date:  2021-12-31       Impact factor: 5.923

Review 7.  Exosomes Immunity Strategy: A Novel Approach for Ameliorating Intervertebral Disc Degeneration.

Authors:  Weihang Li; Shilei Zhang; Dong Wang; Huan Zhang; Quan Shi; Yuyuan Zhang; Mo Wang; Ziyi Ding; Songjie Xu; Bo Gao; Ming Yan
Journal:  Front Cell Dev Biol       Date:  2022-02-10

Review 8.  Notochordal Cell-Based Treatment Strategies and Their Potential in Intervertebral Disc Regeneration.

Authors:  Frances C Bach; Deepani W Poramba-Liyanage; Frank M Riemers; Jerome Guicheux; Anne Camus; James C Iatridis; Danny Chan; Keita Ito; Christine L Le Maitre; Marianna A Tryfonidou
Journal:  Front Cell Dev Biol       Date:  2022-03-14

9.  Circular RNA VMA21 protects against intervertebral disc degeneration through targeting miR-200c and X linked inhibitor-of-apoptosis protein.

Authors:  Xiaofei Cheng; Liang Zhang; Kai Zhang; Guoying Zhang; Ying Hu; Xiaojiang Sun; Changqing Zhao; Hua Li; Yan Michael Li; Jie Zhao
Journal:  Ann Rheum Dis       Date:  2018-01-17       Impact factor: 19.103

Review 10.  Mitochondrial quality control in intervertebral disc degeneration.

Authors:  Yu Song; Saideng Lu; Wen Geng; Xiaobo Feng; Rongjin Luo; Gaocai Li; Cao Yang
Journal:  Exp Mol Med       Date:  2021-07-16       Impact factor: 12.153

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.